Conservative management of a brain abscess in a patient with Staphylococcus lugdunensis endocarditis by Gianella, S et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2006
Conservative management of a brain abscess in a patient with
Staphylococcus lugdunensis endocarditis
Gianella, S; Ulrich, S; Huttner, B; Speich, R
DOI: https://doi.org/10.1007/s10096-006-0169-0
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-156143
Journal Article
Published Version
Originally published at:
Gianella, S; Ulrich, S; Huttner, B; Speich, R (2006). Conservative management of a brain abscess in
a patient with Staphylococcus lugdunensis endocarditis. European Journal of Clinical Microbiology
Infectious Diseases, 25(7):476-478.
DOI: https://doi.org/10.1007/s10096-006-0169-0
BRIEF REPORT
Conservative management of a brain abscess in a patient
with Staphylococcus lugdunensis endocarditis
S. Gianella & S. Ulrich & B. Huttner & R. Speich
Published online: 4 July 2006
# Springer-Verlag 2006
Brain abscess is defined as a focal, intracerebral infection
that begins as a localized area of cerebritis and develops
into a collection of pus surrounded by a well-vascularized
capsule. Microorganisms can gain access to the brain
through several mechanisms, most commonly by direct
extension of an adjacent suppurative focus (i.e. otitis media,
mastoiditis, or sinusitis) or by direct penetration via an open
cerebrospinal fluid leak (e.g. after cranial fracture or
neurosurgical complication). Another mechanism of brain
abscess formation is hematogenous bacterial spread from a
distant focus of infection, such as endocarditis.
Despite the presence of continuous bacteremia, brain
abscess is an uncommon complication after bacterial
endocarditis [1] (less than 5% of cases in most series).
However, endocarditis due to Staphylococcus lugdunensis
follows a more fulminant course, typically resulting in
either cardiac complications or systemic emboli with
metastatic foci of infection. Optimal handling of patients
with bacterial infections of the central nervous system often
requires surgical management; nonetheless, a subset of
patients may be treated with appropriate antimicrobial
therapy alone [2–4]. In this setting, the choice of antibiotic
agents should be based on the results of susceptibility
testing and the drug’s cerebrospinal fluid penetration. Here,
we report a case of brain abscess in a patient with
S. lugdunensis endocarditis involving a native bicuspid
aortic valve. We also review the literature regarding the
conservative management of brain abscesses in this clinical
setting.
A 49-year-old woman with an unremarkable medical
history was admitted to our hospital with fever of 39°C,
right-sided hemiparesis and aphasia. Computed tomography
(CT) scan of the brain suggested an ischemic lesion of the
left external capsule. S. lugdunensis was isolated from all
four of the blood cultures taken upon admission. The
organism was shown to be susceptible to all antibiotics
tested. A transesophageal echocardiograph (TEE) con-
firmed the presence of large vegetations (12×4 mm) on
the bicuspid aortic valve and subsequent regurgitation due
to aortic valve destruction. The diagnosis of endocarditis
due to S. lugdunensis involving a bicuspid aortic valve with
severe aortic valve insufficiency and embolic septic
cerebrovascular insult was established.
Antibiotic therapy with flucloxacillin (2 g iv q4h),
supplemented with gentamicin (80 mg iv tid) for the first
5 days, was started. Body temperature, neurological
deficiencies and inflammatory laboratory values normalized
rapidly and the patient remained hemodynamically stable.
After 6 weeks of antibiotic therapy, TEE showed persistent
aortic valve vegetation and an increased diastolic diameter
of the left ventricle (EDVI: 63 ml/m2). Valve replacement
was subsequently recommended. A second CT scan (Fig. 1)
performed during the pre-operative investigation revealed
the presence of a small abscess (1 cm in diameter) at the
level of the left insula. Given the size of the abscess, the
lack of neurological symptoms and the known tendency
toward development of metastatic lesion secondary to
S. lugdunensis bacteremia, surgical abscess excision was
deferred. Because of its optimal ability to penetrate the
blood brain barrier, rifampin (600 mg orally bid) was added
to the antibiotic regimen.
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After another 2 weeks of medical therapy, CT scan
revealed a reduction in the size of the abscess (0.5 cm). At
this time a mechanical valve was implanted without
complication. Histological examination yielded neither
bacteria nor signs of florid infection. After a total of
10 weeks of intravenous antibiotic therapy, the treatment
was stopped. There were no signs of relapse during the
following 6 months.
Coagulase-negative staphylococci (CoNS) are sapro-
phytes that reside on human skin. In the past, these bacteria
were considered to have little or no pathogenic potential.
Recently, however, CoNS have been recognized as clini-
cally significant pathogens in bloodstream infections,
especially in patients with indwelling prosthetic devices,
foreign bodies and intravascular catheters. Correspondingly,
a multicenter study recently showed that the incidence of
CoNS as a putative agent of native valve endocarditis is
increasing, in particular due to the widespread use of long-
term intravenous catheters [5]. Patients with underlying
congenital or acquired cardiac abnormalities are at partic-
ular risk.
S. lugdunensis was first described in 1988 [6] as a
distinct species within the group of CoNS. S. lugdunensis
appears to be particularly aggressive [7] and therefore must
always be considered as a significant pathogen when
isolated from cultures [8]. Major sources of S. lugdunensis
infections in the community are dental abscesses, cutaneous
infections, infected vascular devices and cardiac pace-
makers [9]. In contrast to other CoNS, this organism
frequently causes native valve endocarditis, mainly involv-
ing the left heart, and is often complicated by rapidly
progressive valve destruction (21%) and paravalvular
abscess formation (23%), generally requiring early valve
replacement [7] in addition to specific antibiotic therapy
[10]. Systemic emboli with metastatic suppurative foci were
seen in 32% of the reported cases [10].
Antibiotic therapy alone in patients with bacterial brain
abscess unrelated to endocarditis was long considered
suboptimal since it prohibits the establishment of an
accurate diagnosis based on microbial specification. Thus,
surgery with abscess debridement was usually performed.
Different studies, however, corroborated the hypothesis that
in select patients, high-dose intravenous antibiotic therapy
is effective [3, 4, 11]. This strategy has been shown to be
successful in high-risk patients, in patients with multiple
abscesses, abscesses at deep or dominant locations, and in
patients affected by concomitant meningitis or ependymitis.
Nevertheless, for abscesses larger than 2.5 cm in diameter,
surgical therapy is still recommended [3].
The optimal duration of antimicrobial therapy for brain
abscesses, alone or related to endocarditis, is not yet
known, but most investigators agree on a long-term
treatment, with the average duration ranging between 4
and 12 weeks [11]. Patients treated with antimicrobial
therapy alone should also receive careful clinical and
radiological follow-up. In stable patients, continuation of
antibiotic therapy in an outpatient setting may be justifiable
and cost-effective. Some authors propose prolonging
antibiotic treatment for up to 6 weeks after successful
abscess resolution is shown by CT scan [12], but premature
cessation may be considered if the neurological status of the
patient is stable, the ESR is within normal limits and
radiographic studies reveal no lesions or a minimal stable
lesion without inflammation [11].
The present case of cerebral abscess as an embolic
complication of infective endocarditis was successfully
managed using conservative methods, and the efficacy of
this approach is supported by the results of our literature
review. The described treatment validates the thesis that in
select clinical settings, it is possible to cure such a serious
disorder without surgical intervention.
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Fig. 1 Pre-operative computed tomography scan of the brain
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